Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care

• Príomhchruthaitheoirí: Xi Chen (Údar), Alexis Laurent (Údar), Zhifeng Liao (Údar), Sandra Jaccoud (Údar), Philippe Abdel-Sayed (Údar), Marjorie Flahaut (Údar), Corinne Scaletta (Údar), Wassim Raffoul (Údar), Lee Ann Applegate (Údar), Nathalie Hirt-Burri (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2023-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Autologous cell therapy manufacturing timeframes constitute bottlenecks in clinical management pathways of severe burn patients. While effective temporary wound coverings exist for high-TBSA burns, any means to shorten the time-to-treatment with cytotherapeutic skin grafts could provide substantial...